PubMed:27172902 / 591-765 JSONTXT

{"project":"LitCoin-sentences","denotations":[{"id":"T4","span":{"begin":0,"end":174},"obj":"Sentence"}],"text":"Cisplatin-treated DCs down-regulated the expression of cell surface molecules (CD80, CD86, MHC class I and II) and up-regulated endocytic capacity in a dose-dependent manner."}

{"project":"LitCoin-entities","denotations":[{"id":"11292","span":{"begin":0,"end":9},"obj":"ChemicalEntity"},{"id":"11293","span":{"begin":79,"end":83},"obj":"GeneOrGeneProduct"},{"id":"11294","span":{"begin":85,"end":89},"obj":"GeneOrGeneProduct"},{"id":"11295","span":{"begin":91,"end":109},"obj":"GeneOrGeneProduct"}],"attributes":[{"id":"A12","pred":"db_id","subj":"11292","obj":"MESH:D002945"},{"id":"A13","pred":"db_id","subj":"11293","obj":"NCBIGene:12519"},{"id":"A14","pred":"db_id","subj":"11294","obj":"NCBIGene:12524"},{"id":"A15","pred":"db_id","subj":"11295","obj":"NCBIGene:14961"},{"id":"A16","pred":"db_id","subj":"11295","obj":"NCBIGene:14972"}],"namespaces":[{"prefix":"_base","uri":"https://w3id.org/biolink/vocab/"},{"prefix":"MESH","uri":"http://id.nlm.nih.gov/mesh/"},{"prefix":"NCBITaxon","uri":"https://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?id="},{"prefix":"NCBIGene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"OMIM","uri":"https://www.omim.org/entry/"},{"prefix":"DBSNP","uri":"https://www.ncbi.nlm.nih.gov/snp/"}],"text":"Cisplatin-treated DCs down-regulated the expression of cell surface molecules (CD80, CD86, MHC class I and II) and up-regulated endocytic capacity in a dose-dependent manner."}

{"project":"LitCoin-GeneOrGeneProduct-v0","denotations":[{"id":"T17","span":{"begin":0,"end":9},"obj":"GeneOrGeneProduct"},{"id":"T18","span":{"begin":27,"end":36},"obj":"GeneOrGeneProduct"},{"id":"T19","span":{"begin":55,"end":67},"obj":"GeneOrGeneProduct"},{"id":"T20","span":{"begin":79,"end":83},"obj":"GeneOrGeneProduct"},{"id":"T21","span":{"begin":85,"end":89},"obj":"GeneOrGeneProduct"},{"id":"T22","span":{"begin":91,"end":102},"obj":"GeneOrGeneProduct"},{"id":"T23","span":{"begin":107,"end":109},"obj":"GeneOrGeneProduct"},{"id":"T24","span":{"begin":118,"end":127},"obj":"GeneOrGeneProduct"},{"id":"T25","span":{"begin":147,"end":151},"obj":"GeneOrGeneProduct"}],"text":"Cisplatin-treated DCs down-regulated the expression of cell surface molecules (CD80, CD86, MHC class I and II) and up-regulated endocytic capacity in a dose-dependent manner."}

{"project":"LitCoin-GeneOrGeneProduct-v2","denotations":[{"id":"T9","span":{"begin":0,"end":9},"obj":"GeneOrGeneProduct"},{"id":"T10","span":{"begin":55,"end":67},"obj":"GeneOrGeneProduct"},{"id":"T11","span":{"begin":79,"end":83},"obj":"GeneOrGeneProduct"},{"id":"T12","span":{"begin":85,"end":89},"obj":"GeneOrGeneProduct"},{"id":"T13","span":{"begin":91,"end":102},"obj":"GeneOrGeneProduct"}],"text":"Cisplatin-treated DCs down-regulated the expression of cell surface molecules (CD80, CD86, MHC class I and II) and up-regulated endocytic capacity in a dose-dependent manner."}

{"project":"LitCoin-GeneOrGeneProduct-v3","denotations":[{"id":"T5","span":{"begin":79,"end":83},"obj":"GeneOrGeneProduct"},{"id":"T6","span":{"begin":85,"end":89},"obj":"GeneOrGeneProduct"},{"id":"T7","span":{"begin":91,"end":102},"obj":"GeneOrGeneProduct"}],"text":"Cisplatin-treated DCs down-regulated the expression of cell surface molecules (CD80, CD86, MHC class I and II) and up-regulated endocytic capacity in a dose-dependent manner."}

{"project":"LitCoin_Mondo_095","denotations":[{"id":"T3","span":{"begin":18,"end":21},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A3","pred":"mondo_id","subj":"T3","obj":"0010155"}],"text":"Cisplatin-treated DCs down-regulated the expression of cell surface molecules (CD80, CD86, MHC class I and II) and up-regulated endocytic capacity in a dose-dependent manner."}

{"project":"LitCoin-Chemical-MeSH-CHEBI","denotations":[{"id":"T10","span":{"begin":0,"end":9},"obj":"ChemicalEntity"}],"attributes":[{"id":"A10","pred":"ID:","subj":"T10","obj":"http://purl.obolibrary.org/obo/CHEBI_27899"}],"text":"Cisplatin-treated DCs down-regulated the expression of cell surface molecules (CD80, CD86, MHC class I and II) and up-regulated endocytic capacity in a dose-dependent manner."}

{"project":"LitCoin-training-merged","denotations":[{"id":"T10","span":{"begin":0,"end":9},"obj":"ChemicalEntity"},{"id":"T7","span":{"begin":91,"end":102},"obj":"GeneOrGeneProduct"},{"id":"T51747","span":{"begin":85,"end":89},"obj":"GeneOrGeneProduct"},{"id":"T63261","span":{"begin":79,"end":83},"obj":"GeneOrGeneProduct"}],"attributes":[{"id":"A10","pred":"ID:","subj":"T10","obj":"http://purl.obolibrary.org/obo/CHEBI_27899"}],"text":"Cisplatin-treated DCs down-regulated the expression of cell surface molecules (CD80, CD86, MHC class I and II) and up-regulated endocytic capacity in a dose-dependent manner."}

{"project":"Inflammaging","denotations":[{"id":"T4","span":{"begin":0,"end":174},"obj":"Sentence"},{"id":"T4","span":{"begin":0,"end":174},"obj":"Sentence"}],"text":"Cisplatin-treated DCs down-regulated the expression of cell surface molecules (CD80, CD86, MHC class I and II) and up-regulated endocytic capacity in a dose-dependent manner."}